Anaplastic Large Cell Lymphoma Terminated Phase Trials for Plerixafor (DB06809)

Also known as: Lymphomas, Anaplastic Large-Cell / Anaplastic large-cell lymphoma / Large cell (Ki-1+) lymphoma / Lymphoma, Large-Cell, Anaplastic / Anaplastic large cell lymphoma, CD30-positive

DBCOND0028602 (Anaplastic Large Cell Lymphoma)TerminatedNot Available IdentifierTitlePurposeDrugs
NCT01408043Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin LymphomaTreatment